You are here

TSRL, INC.

Company Information
Address
540 AVIS DR STE A
ANN ARBOR, MI 48108-7906
United States



Information

UEI: TP74UMNGJDJ1

# of Employees: 9


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. DIPEPTIDE TRANSPORTER EXPRESSION IN VITRO

    Amount: $692,136.00

    N/A

    SBIRPhase II1998Department of Health and Human Services
  2. Adenoviral Mediated Gene Therapy for Experimental Glioma

    Amount: $632,576.00

    Gliomas are the most common primary intracranial brain tumors and are thought to arise as a neoplastransformation of glial cells in the central nervous system. The prognosis for the disease is poor.su ...

    SBIRPhase II1997Department of Health and Human Services
  3. N/A

    Amount: $749,970.00

    N/A

    SBIRPhase II1997Department of Health and Human Services
  4. DIPEPTIDE TRANSPORTER EXPRESSION IN VITRO

    Amount: $100,000.00

    N/A

    SBIRPhase I1996Department of Health and Human Services
  5. PRODRUGS OF BISPHOSPHONATE FOR CALCIUM RELATED DISORDERS

    Amount: $100,000.00

    N/A

    SBIRPhase I1996Department of Health and Human Services
  6. "Protected" Nanoparticles for an Oral Single-Dose Staphylocaccal Enterotoxin B Vaccine

    Amount: $69,902.00

    Conventional methods of immunization in general require multiple injections at certain intervals to achieve the required protective immune response. However, this immunization protocol may not always ...

    SBIRPhase I1995Department of Defense Army
  7. Adenoviral Mediated Gene Therapy for Experimental Glioma

    Amount: $100,000.00

    N/A

    SBIRPhase I1995Department of Health and Human Services
  8. Targeted Delivery of Recombinant Adenovirus to Gut

    Amount: $81,000.00

    Inflammatory bowel disease (IBD) is a collective term that includes Crohn's disease andulcerative colitis. Although both disorders have a distinct clinical course with characteristicpathophysiology, t ...

    SBIRPhase I1994Department of Health and Human Services
  9. TOPICAL DELIVERY OF LIPOSOMALLY ENCAPSULATED INTERFERON

    Amount: $484,173.00

    ABOUT FIVE MILLION AMERICANS SUFFER FROM GENITAL HERPES, WITH AN ESTIMATED ONE-HALF MILLION INDIVIDUALS HAVING BECOME INFECTED IN 1981 ALONE. ALTHOUGH MANY FORMS OF THERAPY HAVE BEEN TESTED, NONE HAS ...

    SBIRPhase II1993Department of Health and Human Services
  10. POSITION-SENSITIVE SCINTILLATION FLOW COUNTER

    Amount: $456,131.00

    A NOVEL PRINCIPLE FOR SIMULTANEOUS SCINTILLATION COUNTING OF MULTIPLE RADIOACTIVE SAMPLES IS PROPOSED. THE IMMEDIATE GOAL OF THIS PROPOSAL IS TO CONSTRUCT AND TEST A SIX-SAMPLE PROTOTYPE DEVICE TO PRO ...

    SBIRPhase II1992Department of Health and Human Services
US Flag An Official Website of the United States Government